First-Line Pembrolizumab Plus Chemotherapy for Advanced Biliary Tract Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-966 Study

Advances in Therapy 2026

View at publisher
Authors: Zhenggang Ren, Tingbo Liang, Shanzhi Gu, Hongfeng Gou, Chuang Peng, Y Y Pan, Tianqiang Song, Haichuan Su, Ke Cao, Houjie Liang, J. Ying, Z M Geng
+12 more Wenchang Yu, Hongyun Zhao, Yuxian Bai, Chunyi Hao, Yimin Mao, Wei Li, Lu Wang, Dongliang Li, Wenmiao Wang, Nan Li, Usha Malhotra, Shukui Qin
DOI: 10.1007/s12325-026-03578-4
Cited by: 1
References: 25

Fields of Study & Subjects

Cholangiocarcinoma and Gallbladder Cancer Studies Gallbladder and Bile Duct Disorders Liver Diseases and Immunity

Publication details

Journal / source
Advances in Therapy
Publisher
Springer Science and Business Media LLC
Volume
43
Issue
9
Pages
3871–3885
Publication date
23 May 2026
Language
EN